Abstract:Ovarian cancer remains one of the most lethal gynaecological malignancies affecting women worldwide; therefore, attention has been focused on identifying new prognostic factors which might help the clinician to select cases who could benefit most from surgery versus cases in which neoadjuvant systemic therapy followed by interval debulking surgery should be performed. The aim of the current paper is to identify whether preoperative inflammation could serve as a prognostic factor for advanced-stage ovarian cancer. Material and methods: The data of 57 patients who underwent to surgery for advanced-stage ovarian cancer between 2014 and 2020 at the Cantacuzino Clinical Hospital were retrospectively reviewed. The receiver operating characteristic curve was used to determine the optimal cut-off value of different inflammatory markers for the overall survival analysis. The analysed parameters were the preoperative level of CA125, monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and systemic inflammation index (SII). Results: Baseline CA125 > 780 μ/mL, NLR ≥ 2.7, MLR > 0.25, PLR > 200 and a systemic immune inflammation index (SII, defined as platelet × neutrophil–lymphocyte ratio) ≥84,1000 were associated with significantly worse disease-free and overall survival in a univariate analysis. In a multivariate analysis, MLR and SII were significantly associated with higher values of overall survival (p < 0.0001 and p = 0.0124); meanwhile, preoperative values of CA125, PLR and MLR were not associated with the overall survival values (p = 0.5612, p = 0.6137 and p = 0.1982, respectively). In conclusion, patients presenting higher levels of MLR and SII preoperatively are expected to have a poorer outcome even if complete debulking surgery is performed and should be instead considered candidates for neoadjuvant systemic therapy followed by interval surgery.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in patients with ovarian cancer peritoneal implantation, whether preoperative inflammatory markers can be used as predictors of long - term prognosis. Specifically, the study aims to analyze the correlation between the most common inflammatory markers and tumor markers and the long - term prognosis of ovarian cancer patients, in order to provide a basis for clinicians to choose surgery or neoadjuvant systemic therapy. ### Research Background Ovarian cancer is one of the most deadly gynecological malignancies in women. Even after complete cytoreductive surgery, the long - term prognosis of patients is still poor. Therefore, researchers focus on finding other prognostic factors, such as coagulation status or inflammatory status, to predict which patients may obtain the best long - term prognosis. ### Research Objectives The main objective of this study is to explore whether preoperative inflammatory markers can be used as prognostic factors for patients with advanced ovarian cancer. Specifically, the study analyzed the relationship between the following inflammatory markers and the long - term prognosis of patients: - **CA125**: A commonly used ovarian cancer marker. - **Monocyte - to - lymphocyte ratio (MLR)** - **Platelet - to - lymphocyte ratio (PLR)** - **Neutrophil - to - lymphocyte ratio (NLR)** - **Systemic immune - inflammatory index (SII)**: Defined as the platelet count multiplied by the neutrophil - to - lymphocyte ratio. ### Research Methods The study retrospectively analyzed the data of 57 patients with advanced ovarian cancer who underwent surgery at the Cantacuzino Clinical Hospital between 2014 and 2020. The optimal cut - off values of different inflammatory markers were determined by the receiver operating characteristic curve (ROC curve), and the survival curves of different groups were compared using Kaplan - Meier analysis and log - rank test. ### Main Findings - Patients with baseline CA125 > 780 µ/mL, NLR ≥ 2.7, MLR > 0.25, PLR > 200 and SII ≥ 841,000 showed significantly worse disease - free survival and overall survival in univariate analysis. - In multivariate analysis, MLR and SII were significantly associated with higher overall survival rates (p < 0.0001 and p = 0.0124), while preoperative CA125, PLR and MLR levels were not significantly associated with overall survival rates (p = 0.5612, p = 0.6137 and p = 0.1982). ### Conclusions Patients with higher preoperative MLR and SII levels have a poor prognosis even after complete cytoreductive surgery. Therefore, these patients should be considered for neoadjuvant systemic therapy followed by interval surgery. ### Keywords - Peritoneal implantation - Preoperative inflammation - Platelet - to - lymphocyte ratio - Monocyte - to - lymphocyte ratio - Systemic immune - inflammatory index Through these research results, clinicians can better select patients suitable for surgery, thereby improving the treatment effect and patient survival rate.

Prognostic Significance of Preoperative Inflammation Markers on the Long-Term Outcomes in Peritoneal Carcinomatosis from Ovarian Cancer

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma

The Influence of Inflammatory and Nutritional Status on the Long-Term Outcomes in Advanced Stage Ovarian Cancer

Are preoperative serum cancer antigen 125 levels a prognostic factor for outcome in epithelial ovarian cancer? A systematic review

The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer

Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer

The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer

Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients

Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review

Prognostic Significance And Predictors Of The System Inflammation Score In Ovarian Clear Cell Carcinoma

Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery

Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications

Association between alteration of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, cancer antigen-125 and surgical outcomes in advanced stage ovarian cancer patient who received neoadjuvant chemotherapy

Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study

High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence

Exploratory Evaluation of Pre-Treatment Inflammation Profiles in Patients with Colorectal Cancer

Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy

Preoperative prognostic factors for obstructive colorectal cancer

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer